FindTrial
Sign In

The clinical value of magnetic resonance and ultrasound in the diagnosis of different molecular subtypes of breast cancer

The clinical value of magnetic resonance and ultrasound in the diagnosis of different molecular subtypes of breast cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119522
Enrollment
Unknown
Registered
2026-02-28
Start date
2026-02-28
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Triple-negative group :None
HER2 overexpression group:None
Luminal group:None

Sponsors

Ningbo Medical Centre Lihuili Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
28 Years to 88 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as breast cancer through pathological examination; 2. Underwent magnetic resonance and ultrasound examinations and had complete data; 3 First admission without receiving radiotherapy, chemotherapy or drug treatment; 4. Histological grade I - III; 5. Unilateral breast cancer.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Those with other tumors; 3. Those with inflammatory breast skin; 4. Those with poor quality of clinical imaging data and significant artifacts; 5. Those with contraindications for MRI examination; 6. Those with breast implants; 7. Those with lesion diameters <= 5 mm; 8. Those with incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
AUC values ;sensitivity;specificity;—

Countries

China

Contacts

Public ContactWang Yingying

Ningbo Medical Centre Lihuili Hospital

wyy2022090109@163.com+86 574 8707 8705

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026